Search
Session handouts and meetings archive
Handouts ... 2025 Innovation Academy, Chicago, IL, July 10-13 2025 Annual Meeting, Orlando, FL, March 7-11 2024 Innovation Academy, Seattle, WA, August 1-4 2024 Annual Meeting, San Diego, CA, March 8-12 2023 Innovation Academy, Tampa, FL, August 10-13 2023 Annual Meeting, New Orleans, LA, March 17-21 Sessions ... 2025 Innovation
CME & session evaluation archive
Claim CME & submit session evaluations ... Claim CME credit and submit session evaluations for attending previous Academy meetings: ... 2025 Innovation Academy, Chicago, IL, July 10-13 2025 Annual Meeting, Orlando, FL, March 7-11 2024 Innovation Academy, Seattle, WA, August 1-4 2024 Annual Meeting, San Diego, CA, March 8-12 2023
AADA hosts largest Capitol Hill skin cancer check in a decade
On May 15, the AADA hosted its 10th annual Capitol Hill Skin Cancer Check and Health Fair with the Congressional Skin Cancer Caucus. This event was our largest to date, hosting 198 Hill staffers and 11 members of Congress, performing 127 skin checks, and providing 75 Reveal camera image results.
PDF of Nominating Committee Member Rep. Regional Map
the PE WEST REGION OF THE UNITED STATES QC ON AND CANADIAN PROVINCES ONLY NS (Shown in Pink) ND WA
PDF of Board of Directors Regional Map
NL 9 BC 40 NL AB SK MB 9 47 4 12 PE QC 1 ON 64 NS 140 20 WA ND MT NB 333 46 22
Academy physician leaders meet with federal legislators
On June 4, AADA physician leaders met with legislators in Washington, D.C., as part of the House Call on the Mall fundraiser hosted by the National Republican Congressional Committee and Rep. John Joyce, MD, FAAD (R-PA). During the event, AADA leaders reiterated the importance of Medicare physician payment reform. ...
2025 AAD Innovation Academy Attendee Statistics
Innovation Academy Attendance over the years: 2024 – Seattle, WA ..................................
2024 AAD Innovation Academy | Official exhibitor suppliers
Experient) is the official housing provider for the 2024 AAD Innovation Academy Meeting in Seattle, WA
AADA hosts 10th annual Capitol Hill Skin Cancer Check and Health Fair
Moving the needle ... By Apoorva Stull, Senior Manager, Advocacy Communications, May 1, 2024 DermWorld ... breaks down the latest highlights of AADA advocacy activities at the federal and state legislative and regulatory level. On May 15, the AADA hosted its 10th annual Capitol Hill Skin Cancer Check and Health
PDF of BF transplant dermatology
Am J Transplant. 2017 Nov;17(11):2782-2789. doi: 10.1111/ajt.14337. Epub 2017 May 30.
Advocacy Update Feb. 4 2025
IN THIS ISSUE / Feb. 4, 2025 Physician champions introduce Medicare physician payment fix in House Academy joins coalition urging less regulatory burdens in Medicare Advantage and Part D program AADA urges CMS to improve MVP framework Become an AADA Advocacy Key Contact Support dermatology champions in Congress through SkinPAC
Taking the challenge: Social media, adolescents, and the skin
By Albert C. Yan, MD June 12, 2019 Vol. 1, No. 14 Patterned skin injury can raise the specter of non-accidental trauma. However, over the past decade or so, striking examples of patterned skin injury have emerged among adolescents and pre-teens that share certain features: these are self-induced voluntarily; the
Advocacy Update Dec 9, 2025
IN THIS ISSUE / Dec. 9, 2025 AADA endorses annual inflationary update to Medicare payment legislation Upcoming formulary prior authorization changes to Blue Cross Blue Shield’s federal employee coverage Podcast highlights advocacy on dermatopathology payer and regulatory challenges AMA offering $1 million in community health program grants Peter Friedman, MD,
Advocacy Update Feb. 18 2025
IN THIS ISSUE / Feb. 18, 2025 AADA, house of medicine demand reversal of Medicare cut and provide a pay boost AADA highlights need for Medicare physician payment reform at House Committee on Ways and Means hearing Dermatology addresses new CLIA requirements for lab directors Legislators reject pharmacists’ effort to
Advocacy Update Mar. 18, 2025
IN THIS ISSUE / Mar. 18, 2025 AADA outraged that Congress passed government funding without doc fix AADA advocates for dermatologists in CLIA lab director requirements FDA testing confirms minimal benzene in most benzoyl peroxide acne products, some voluntary recalls issued Add your voice and become an AADA Advocacy Key
PDF of Histiocytosis
Kornik RI, Naik HB, Lee CC, Estrada-Veras J, Gahl WA, Cowen EW.
Glucose monitors: Not as sweet as they seem
By Christen M. Mowad, MD Oct. 9, 2019 Vol. 1, No. 31 ... The next contact allergen of the year has been announced early by the American Contact Dermatitis Society and it is an acrylate, isobornyl acrylate. (1) This chemical is a photopolymerizable monomer that has been used in industrial
Researching therapeutic reformation of the capillary malformation: Arteriovenous Malformation Syndrome
By Warren R. Heymann, MD June 17, 2020 Vol. 2, No. 24 Small cutaneous lesions may have profound systemic implications. Astute dermatologists will recognize these lesions and assess patients accordingly, often to the surprise of referring physicians and patients alike. ... The Capillary Malformation – Arteriovenous Malformation (CM-AVM) syndrome was
2020 Legislative Conference Overview of Asks
Suzan DelBene, D-WA, Mike Kelly, R-PA, Ami Bera, MD, D-CA, and Roger Marshall, MD, R-KS.
Key messages to communicate about Indoor tanning
Key messages ... Using indoor tanning beds can increase your risk of skin cancer, including melanoma, the deadliest form of skin cancer. (1-15) ... Using tanning beds before age 20 can increase your chances of developing melanoma by 47%, and the risk increases with each use. (16) ... Women younger
2024 AAD Annual Meeting Sponsorship Prospectus
sponsorships are also available for the 2024 AAD Innovation Academy (formerly Summer Meeting) in Seattle, WA
After 23 years, a syndrome converted me into an eflornithine believer
By Warren R. Heymann, MD, FAAD July 12, 2023 Vol. 5, No. 28 I learned that Vaniqa (eflornithine - ... α -difluoromethylornithine [DFMO]) was discontinued. Topical eflornithine was released in 2000 to reduce facial hirsutism. When the drug was released, I recall being fascinated by the premise of its mechanism.
Biotin supplementation for hair and nail health: Does it pass the test?
By Warren R. Heymann, MD, FAAD November 17, 2021 Vol. 3, No. 46 When patients ask me about biotin supplementation for their hair or nails, the usual question is what dose they should take, not whether or not it has any value. High dose over-the-counter biotin supplements (≥ 5 mg/day,
March 20, 2023 AAD/A Board of Directors agenda
Resort & Spa, Itasca, IL 2024 Innovation Academy – August 1-4, 2024 (Thurs – Sun) Seattle, WA
Agenda of the July 23, 2022 AAD/A Board of Directors meeting.
600 PM – 9:00 PM (Central) 2024 Innovation Academy Meeting – Seattle, WA
Promising therapeutic developments for cutaneous lupus erythematosus: Interfering with interferon
By Warren R. Heymann, MD, FAAD Aug. 17, 2022 Vol. 4, No. 33 Disfigurement due to scars and dyspigmentation complicating discoid lupus erythematosus (DLE) can be devastating. The cornerstones of therapy for cutaneous lupus erythematosus (CLE) are steroids (topical, intralesional, systemic) and antimalarials (hydroxychloroquine, chloroquine, quinacrine). Secondary agents include immunosuppressive
The nexus of VEXAS syndrome
By Warren R. Heymann, MD, FAAD December 1, 2021 Vol. 3, No. 47 You may not be familiar with VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome, but it is conceivable that you have already unknowingly encountered patients with the disorder. ... To appreciate the clinical nuances of the VEXAS
AAD Innovation Academy 2020 Technical Exhibitor Prospectus
Friday. 70 Pike St., Seattle, WA 98101 Welcome Reception (Exhibits Open) 3 Thursday, August 13 ......
Agenda for the Nov. 5, 2022 meeting of the AAD and AADA Board of Directors meetings.
6:00 PM – 9:00 PM (Central) 2024 Innovation Academy Meeting – Seattle, WA
Exchanging plasma exchange for a novel approach: The potential of FcRn antagonists in dermatologic autoimmune disease
By Warren R. Heymann, MD, FAAD Nov. 1, 2023 Vol. 5, No. 44 Pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are potentially life-threatening disorders demanding aggressive therapy with all the finesse and skill that dermatologists can muster. PV is characterized by IgG autoantibodies targeting desmoglein (Dsg)‐3, which is associated with
PDF of proposed guidelines on AD and phototherapy
137- 629 40. 630 51. van Joost T, Heule F, Korstanje M, van den Broek MJ, Stenveld HJ , van Vloten WA
2023 Annual Meeting Technical Exhibit Prospectus
ORLEANS, LA• March 17-21, 2023 TAMPA, FL• August 10-13, 2023 SAN DIEGO, CA • March 8-12, 2024 SEATTLE, WA
PDF of AD guidelines on phototherapy supplement
338(8760):137-140. 7. van Joost T, Heule F, Korstanje M, van den Broek MJ, Stenveld HJ, van Vloten WA
PDF of AAD Atopic Dermatitis pediatric comorbid conditions guideline draft
Bocchini CE, Mason EO, Hulten KG, Hammerman WA , Kaplan SL.
PDF of gross and micro abstract programs
High WA, Hoang MP, Stevens K, Cockerell CJ. Late-stage nodular erythema elevatum diutinum.
PDF of AAD Atopic Dermatitis pediatric comorbid conditions supplement draft
Bocchini CE, Mason EO, Hulten KG, Hammerman WA , Kaplan SL.